Standard
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers : A retrospective nested case-control study in two prospective cohorts. / Wu, Wendy Yi-Ying; Haider, Zahra; Feng, Xiaoshuang; Heath, Alicia K.; Tjønneland, Anne; Agudo, Antonio; Masala, Giovanna; Robbins, Hilary A.; Huerta, Maria-Jose; Guevara, Marcela; Schulze, Matthias B.; Rodriguez-Barranco, Miguel; Vineis, Paolo; Tumino, Rosario; Kaaks, Rudolf; Fortner, Renee T.; Sieri, Sabina; Panico, Salvatore; Nost, Therese Haugdahl; Sandanger, Torkjel M.; Braaten, Tonje; Johansson, Mattias; Melin, Beatrice; Johansson, Mikael.
I:
International Journal of Cancer, Bind 159, Nr. 9, 2023, s. 2002-2010.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Wu, WY-Y, Haider, Z, Feng, X, Heath, AK
, Tjønneland, A, Agudo, A, Masala, G, Robbins, HA, Huerta, M-J, Guevara, M, Schulze, MB, Rodriguez-Barranco, M, Vineis, P, Tumino, R, Kaaks, R, Fortner, RT, Sieri, S, Panico, S, Nost, TH, Sandanger, TM, Braaten, T, Johansson, M, Melin, B & Johansson, M 2023, '
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts',
International Journal of Cancer, bind 159, nr. 9, s. 2002-2010.
https://doi.org/10.1002/ijc.34340APA
Wu, W. Y-Y., Haider, Z., Feng, X., Heath, A. K.
, Tjønneland, A., Agudo, A., Masala, G., Robbins, H. A., Huerta, M-J., Guevara, M., Schulze, M. B., Rodriguez-Barranco, M., Vineis, P., Tumino, R., Kaaks, R., Fortner, R. T., Sieri, S., Panico, S., Nost, T. H., ... Johansson, M. (2023).
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
International Journal of Cancer,
159(9), 2002-2010.
https://doi.org/10.1002/ijc.34340Vancouver
Wu WY-Y, Haider Z, Feng X, Heath AK
, Tjønneland A, Agudo A o.a.
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
International Journal of Cancer. 2023;159(9):2002-2010.
https://doi.org/10.1002/ijc.34340Author
Wu, Wendy Yi-Ying ; Haider, Zahra ; Feng, Xiaoshuang ; Heath, Alicia K. ; Tjønneland, Anne ; Agudo, Antonio ; Masala, Giovanna ; Robbins, Hilary A. ; Huerta, Maria-Jose ; Guevara, Marcela ; Schulze, Matthias B. ; Rodriguez-Barranco, Miguel ; Vineis, Paolo ; Tumino, Rosario ; Kaaks, Rudolf ; Fortner, Renee T. ; Sieri, Sabina ; Panico, Salvatore ; Nost, Therese Haugdahl ; Sandanger, Torkjel M. ; Braaten, Tonje ; Johansson, Mattias ; Melin, Beatrice ; Johansson, Mikael. / Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers : A retrospective nested case-control study in two prospective cohorts. I: International Journal of Cancer. 2023 ; Bind 159, Nr. 9. s. 2002-2010.
Bibtex
@article{8980093c78f74e93b5d859448c2a2f02,
title = "Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts",
abstract = "The EarlyCDT-Lung test is a blood-based autoantibody assay intended to identify high-risk individuals for low-dose computed tomography lung cancer screening. However, there is a paucity of evidence on the performance of the EarlyCDT-Lung test in ever-smokers. We conducted a nested case-control study within two prospective cohorts to evaluate the risk-discriminatory performance of the EarlyCDT-Lung test using prediagnostic blood samples from 154 future lung cancer cases and 154 matched controls. Cases were selected from those who had ever smoked and had a prediagnostic blood sample",
keywords = "biomarkers, EarlyCDT-Lung test, lung cancer, prediagnostic samples, AUTOANTIBODY TEST, VALIDATION",
author = "Wu, {Wendy Yi-Ying} and Zahra Haider and Xiaoshuang Feng and Heath, {Alicia K.} and Anne Tj{\o}nneland and Antonio Agudo and Giovanna Masala and Robbins, {Hilary A.} and Maria-Jose Huerta and Marcela Guevara and Schulze, {Matthias B.} and Miguel Rodriguez-Barranco and Paolo Vineis and Rosario Tumino and Rudolf Kaaks and Fortner, {Renee T.} and Sabina Sieri and Salvatore Panico and Nost, {Therese Haugdahl} and Sandanger, {Torkjel M.} and Tonje Braaten and Mattias Johansson and Beatrice Melin and Mikael Johansson",
year = "2023",
doi = "10.1002/ijc.34340",
language = "English",
volume = "159",
pages = "2002--2010",
journal = "Acta - Unio Internationalis Contra Cancrum",
issn = "0898-6924",
publisher = "JohnWiley & Sons, Inc.",
number = "9",
}
RIS
TY - JOUR
T1 - Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers
T2 - A retrospective nested case-control study in two prospective cohorts
AU - Wu, Wendy Yi-Ying
AU - Haider, Zahra
AU - Feng, Xiaoshuang
AU - Heath, Alicia K.
AU - Tjønneland, Anne
AU - Agudo, Antonio
AU - Masala, Giovanna
AU - Robbins, Hilary A.
AU - Huerta, Maria-Jose
AU - Guevara, Marcela
AU - Schulze, Matthias B.
AU - Rodriguez-Barranco, Miguel
AU - Vineis, Paolo
AU - Tumino, Rosario
AU - Kaaks, Rudolf
AU - Fortner, Renee T.
AU - Sieri, Sabina
AU - Panico, Salvatore
AU - Nost, Therese Haugdahl
AU - Sandanger, Torkjel M.
AU - Braaten, Tonje
AU - Johansson, Mattias
AU - Melin, Beatrice
AU - Johansson, Mikael
PY - 2023
Y1 - 2023
N2 - The EarlyCDT-Lung test is a blood-based autoantibody assay intended to identify high-risk individuals for low-dose computed tomography lung cancer screening. However, there is a paucity of evidence on the performance of the EarlyCDT-Lung test in ever-smokers. We conducted a nested case-control study within two prospective cohorts to evaluate the risk-discriminatory performance of the EarlyCDT-Lung test using prediagnostic blood samples from 154 future lung cancer cases and 154 matched controls. Cases were selected from those who had ever smoked and had a prediagnostic blood sample
AB - The EarlyCDT-Lung test is a blood-based autoantibody assay intended to identify high-risk individuals for low-dose computed tomography lung cancer screening. However, there is a paucity of evidence on the performance of the EarlyCDT-Lung test in ever-smokers. We conducted a nested case-control study within two prospective cohorts to evaluate the risk-discriminatory performance of the EarlyCDT-Lung test using prediagnostic blood samples from 154 future lung cancer cases and 154 matched controls. Cases were selected from those who had ever smoked and had a prediagnostic blood sample
KW - biomarkers
KW - EarlyCDT-Lung test
KW - lung cancer
KW - prediagnostic samples
KW - AUTOANTIBODY TEST
KW - VALIDATION
U2 - 10.1002/ijc.34340
DO - 10.1002/ijc.34340
M3 - Journal article
C2 - 36305647
VL - 159
SP - 2002
EP - 2010
JO - Acta - Unio Internationalis Contra Cancrum
JF - Acta - Unio Internationalis Contra Cancrum
SN - 0898-6924
IS - 9
ER -
